What does the current endocrinology literature say about metformin versus spironolactone for treating hirsutism associated with polycystic ovary syndrome?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What does the current endocrinology literature say about metformin versus spironolactone for treating hirsutism associated with polycystic ovary syndrome?
3 real searches · 1 real-search pass
2023 international evidence-based guideline PCOS hirsutism metformin anti-androgens spironolactone recommendationsGoogle ↗
OBSERVED
systematic review meta-analysis metformin spironolactone hirsutism PCOS comparison 2024 2025Google ↗
OBSERVED
Endocrine Society hirsutism guideline metformin not recommended spironolactone oral contraceptivesGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2023 international evidence-based guideline PCOS hirsutism metformin anti-androgens spironolactone recommendations Google ↗
systematic review meta-analysis metformin spironolactone hirsutism PCOS comparison 2024 2025 Google ↗
Endocrine Society hirsutism guideline metformin not recommended spironolactone oral contraceptives Google ↗
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · pmc.ncbi.nlm.nih.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · pmc.ncbi.nlm.nih.gov
- Hirsutism Guideline Resources · support.endocrine.org
- Short-Term, Low-Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome-A Systematic Review · pubmed.ncbi.nlm.nih.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polyendocrine Metabolic Ovarian Syndrome (2023) | American Society for Reproductive Medicine · asrm.org
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2023 international evidence-based guideline PCOS hirsutism metformin anti-androgens spironolactone recommendations OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
systematic review meta-analysis metformin spironolactone hirsutism PCOS comparison 2024 2025 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Endocrine Society hirsutism guideline metformin not recommended spironolactone oral contraceptives OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |